Nutrien Ltd. NTR
71.83 USD +2.51 (+3.62%)
Nov 4, 2026, 2:52 PM EST
68.85 Day range 72.14
53.65 52-week range 85.36
- YTD
- +16.37%
- 1 year
- +33.90%
Analyst view
Consensus: buy
Buy
Price target (mean) 77.04 +7.3% upside
Now 71.83
- Target (low)
- 62.00
- Target (mean)
- 77.04
- Target (high)
- 90.00
Ratings (0m) 26 15 buy · 9 hold · 2 sell
- Strong buy7
- Buy8
- Hold9
- Sell2
- Strong sell0
Recommendation trend
- This month 26
- 1 month ago 26
- 2 months ago 25
- 3 months ago 24
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.77335 | 0.59 – 0.99 | 0.97 | -20.3% | 5.67B | -1.2% | 16 |
| Next quarter | 1.02 | 0.80 – 1.21 | 0.83 | +23.3% | 5.30B | +3.1% | 15 |
| Current year | 4.94 | 4.36 – 5.35 | 4.56 | +8.4% | 27.69B | +6.7% | 21 |
| Next year | 5.08 | 4.10 – 6.72 | 4.94 | +2.6% | 27.48B | -0.8% | 23 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | UBS | Maintained | Sell | Sell |
| Oct 27, 2026 | Freedom Broker | Initiated | — | Hold |
| Oct 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 18, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Sep 11, 2026 | Keybanc | Initiated | — | Sector Weight |
| Aug 11, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 27, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 23, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 16, 2026 | Jefferies | Downgrade | Buy | Hold |
| Jul 14, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jul 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 30, 2026 | Scotiabank | Upgrade | Sector Perform | Sector Outperform |
| May 12, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| May 11, 2026 | UBS | Maintained | Sell | Sell |
| May 11, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 11, 2026 | Scotiabank | Maintained | Sector Perform | Sector Perform |
| Apr 30, 2026 | CIBC | Maintained | Outperformer | Outperformer |
| Apr 27, 2026 | Barclays | Upgrade | Equal-Weight | Overweight |
| Apr 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 20, 2026 | Scotiabank | Maintained | Sector Perform | Sector Perform |
| Apr 8, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 26, 2026 | UBS | Downgrade | Neutral | Sell |
| Mar 18, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Mar 18, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Mar 17, 2026 | CIBC | Maintained | Outperformer | Outperformer |
| Mar 13, 2026 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Mar 12, 2026 | Jefferies | Upgrade | Hold | Buy |
| Mar 3, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 23, 2026 | Jefferies | Maintained | Hold | Hold |
